Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/34580031/ below:

Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report

Affiliations

• ¹ Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY.
• ² Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY.
• ³ Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY. Electronic address: nkaltork@med.cornell.edu.

• PMID: 34580031
• PMCID: PMC8403338
• DOI: 10.1016/j.cllc.2021.08.010

Item in Clipboard

Nathan Mynard et al. Clin Lung Cancer. 2022 May.

• ¹ Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY.
• ² Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY.
• ³ Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY. Electronic address: nkaltork@med.cornell.edu.

• PMID: 34580031
• PMCID: PMC8403338
• DOI: 10.1016/j.cllc.2021.08.010

Item in Clipboard

Introduction: The COVID-19 pandemic reached New York City in early March 2020 resulting in an 11-week lockdown period to mitigate further spread. It has been well documented that cancer care was drastically affected as a result. Given New York City's early involvement, we attempted to identify any stage shift that may have occurred in the diagnoses of non-small cell lung cancer (NSCLC) at our institution as a result of these lockdowns.

Patients and methods: We conducted a retrospective review of a prospective database of lung cancer patients at our institution from July 1, 2019 until March 31, 2021. Patients were grouped by calendar year quarter in which they received care. Basic demographics and clinical staging were compared across quarters.

Results: Five hundred and fifty four patients were identified that underwent treatment during the time period of interest. During the lockdown period, there was a 50% reduction in the mean number of patients seen (15 ± 3 vs. 28 ± 7, P = .004). In the quarter following easing of restrictions, there was a significant trend towards earlier stage (cStage I/II) disease. In comparison to quarters preceding the pandemic lockdown, there was a significant increase in the proportion of patients with Stage IV disease in the quarters following phased reopening (P = .026).

Conclusion: After a transient but significant increase in Stage I/II disease with easing of restrictions there was a significant increase in patients with Stage IV disease. Extended longitudinal studies must be conducted to determine whether COVID-19 lockdowns will lead to further increases in the proportion of patients with advanced NSCLC.

Keywords: Cancer care delays; NSCLC; Pandemic; SARS-CoV-2; Thoracic oncology.

Copyright © 2021 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Graphical representation of the monthly…

Graphical representation of the monthly and quarterly sum of patient encounters during the…

Graphical representation of the monthly and quarterly sum of patient encounters during the study time-period. The blue line represents monthly sums, and the orange boxes represent quarterly sums. The asterisk highlights the yearly quarter most affected by the New York State lockdown.

Quarterly clinical stage distribution as…

Quarterly clinical stage distribution as a percentage of the total diagnoses across the…

Quarterly clinical stage distribution as a percentage of the total diagnoses across the study time-period. The asterisk highlights the yearly quarter with patient volume most affected by the New York State lockdown.

• COVID-related "lockdowns" and birth rates in New York.

  McLaren RA Jr, Trejo FE, Blitz MJ, Bianco A, Limaye M, Brustman L, Bernstein PS, Roman AS, Stone J, Minkoff H. McLaren RA Jr, et al. Am J Obstet Gynecol MFM. 2021 Nov;3(6):100476. doi: 10.1016/j.ajogmf.2021.100476. Epub 2021 Sep 1. Am J Obstet Gynecol MFM. 2021. PMID: 34478877 Free PMC article.

• Bend but don't break: Experience of a diverse New York City lung cancer screening program during the first year of the COVID-19 pandemic.

  Stahl MC, Shamah S, Wattamwar K, Furlani AC, Serrano M, Haramati LB. Stahl MC, et al. Clin Imaging. 2023 Aug;100:1-6. doi: 10.1016/j.clinimag.2023.04.011. Epub 2023 Apr 25. Clin Imaging. 2023. PMID: 37120922 Free PMC article.

• Impact of COVID-19 Pandemic on Non-Small Cell Lung Cancer Care.

  Zhai Y, Chopra P, Kang D, Robert NJ, Zhang W. Zhai Y, et al. Curr Oncol. 2023 Jan 6;30(1):769-785. doi: 10.3390/curroncol30010059. Curr Oncol. 2023. PMID: 36661708 Free PMC article.

• Effect of national and local lockdowns on the control of COVID-19 pandemic: a rapid review.

  Caristia S, Ferranti M, Skrami E, Raffetti E, Pierannunzio D, Palladino R, Carle F, Saracci R, Badaloni C, Barone-Adesi F, Belleudi V, Ancona C; AIE working group on the evaluation of the effectiveness of lockdowns. Caristia S, et al. Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):60-68. doi: 10.19191/EP20.5-6.S2.104. Epidemiol Prev. 2020. PMID: 33412795 Review. English.

• Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?

  Oh KB, Doherty TM, Vetter V, Bonanni P. Oh KB, et al. Expert Rev Vaccines. 2022 Nov;21(11):1541-1553. doi: 10.1080/14760584.2022.2117693. Epub 2022 Sep 5. Expert Rev Vaccines. 2022. PMID: 36039786 Review.

• Unveiling the Effects of the COVID-19 Pandemic on Lung Cancer Surgery.

  Cozma GV, Muntean C, Faur AM, Gaborean V, Petrache IA, Feier CVI. Cozma GV, et al. Medicina (Kaunas). 2024 Jun 11;60(6):964. doi: 10.3390/medicina60060964. Medicina (Kaunas). 2024. PMID: 38929581 Free PMC article.

• Shift in lung cancer stage at diagnosis during the COVID-19 pandemic in New York City.

  Flores R, Alpert N, McCardle K, Taioli E. Flores R, et al. Transl Lung Cancer Res. 2022 Jul;11(7):1514-1516. doi: 10.21037/tlcr-22-191. Transl Lung Cancer Res. 2022. PMID: 35958333 Free PMC article. No abstract available.

• Death by a thousand delays.

  Sadeghi JK, Reza JA, Miller C, Cooke DT, Erkmen C. Sadeghi JK, et al. JTCVS Open. 2024 Jan 10;18:353-359. doi: 10.1016/j.xjon.2024.01.005. eCollection 2024 Apr. JTCVS Open. 2024. PMID: 38690410 Free PMC article. No abstract available.

• Lung cancer and Covid-19: lessons learnt from the pandemic and where do we go from here?

  Maxwell SS, Weller D. Maxwell SS, et al. NPJ Prim Care Respir Med. 2022 May 30;32(1):19. doi: 10.1038/s41533-022-00283-x. NPJ Prim Care Respir Med. 2022. PMID: 35637231 Free PMC article.

• Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis.

  Wang L, Wang Y, Cheng X, Li X, Li J. Wang L, et al. Transl Oncol. 2023 Feb;28:101605. doi: 10.1016/j.tranon.2022.101605. Epub 2022 Dec 19. Transl Oncol. 2023. PMID: 36568513 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3